Literature DB >> 30249623

Childhood Seizures After Phototherapy.

Thomas B Newman1,2,3, Yvonne W Wu2,4, Michael W Kuzniewicz2,3, Barbara A Grimes5, Charles E McCulloch5.   

Abstract

: media-1vid110.1542/5804915133001PEDS-VA_2018-0648Video Abstract
BACKGROUND AND OBJECTIVES: In a recent Danish study, researchers found an increased risk of childhood epilepsy after phototherapy but only in boys. We investigated this association in a Kaiser Permanente Northern California cohort.
METHODS: From 499 642 infants born at ≥35 weeks' gestation in 1995-2011 followed for ≥60 days, we excluded 1773 that exceeded exchange transfusion thresholds and 1237 with seizure diagnoses at <60 days. We ascertained phototherapy, covariates, and outcomes from electronic records and existing databases. Our primary outcome was ≥1 encounter with a seizure diagnosis plus ≥1 prescription for an antiepileptic drug. We used Cox and Poisson models to adjust for bilirubin levels and other confounding variables.
RESULTS: A total of 37 683 (7.6%) infants received any phototherapy. The mean (SD) follow-up time was 8.1 (5.2) years. The crude incidence rate per 1000 person-years of the primary outcome was 1.24 among phototherapy-exposed children and 0.76 among those unexposed (rate ratio: 1.63; 95% confidence interval [CI]: 1.44 to 1.85). The adjusted hazard ratio (aHR) was 1.22 (95% CI: 1.05 to 1.42; P = .009). Boys were at higher risk of seizures overall (aHR = 1.18; 95% CI: 1.10 to 1.27) and had a higher aHR for phototherapy (1.33; 95% CI: 1.10 to 1.61) than girls (1.07; 95% CI: 0.84 to 1.37), although effect modification by sex was not statistically significant (P = .17). The adjusted 10-year excess risks per 1000 were 2.4 (95% CI: 0.6 to 4.1) overall, 3.7 (95% CI: 1.2 to 6.1) in boys, and 0.8 (95% CI: -1.7 to 3.2) in girls.
CONCLUSIONS: Phototherapy in newborns is associated with a small increased risk of childhood seizures, even after adjusting for bilirubin values, and the risk is more significant in boys.
Copyright © 2018 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2018        PMID: 30249623     DOI: 10.1542/peds.2018-0648

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Screening for Neonatal Hyperbilirubinemia-First Do No Harm?

Authors:  Scott D Grosse; Lisa A Prosser; Jeffrey R Botkin
Journal:  JAMA Pediatr       Date:  2019-07-01       Impact factor: 16.193

Review 2.  Neonatal Jaundice and Autism: Precautionary Principle Invocation Overdue.

Authors:  Vera K Wilde
Journal:  Cureus       Date:  2022-02-23

3.  Avoiding Harm From Hyperbilirubinemia Screening-Reply.

Authors:  Scott D Grosse; Lisa A Prosser; Jeffrey R Botkin
Journal:  JAMA Pediatr       Date:  2019-10-07       Impact factor: 16.193

4.  Unbound bilirubin measurements in term and late-preterm infants.

Authors:  Thomas Hegyi; Dalya Chefitz; Alan Weller; Andrew Huber; Mary Carayannopoulos; Alan Kleinfeld
Journal:  J Matern Fetal Neonatal Med       Date:  2020-05-04

5.  Phototherapy for neonatal hyperbilirubinaemia: Unresolved aspects & future directions.

Authors:  Niranjan Thomas; Thangaraj Abiramalatha
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 2.375

Review 6.  Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis.

Authors:  Ilari Kuitunen; Panu Kiviranta; Ulla Sankilampi; Marjo Renko
Journal:  World J Pediatr       Date:  2022-06-11       Impact factor: 9.186

7.  Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial.

Authors:  Cody Arnold; Jon E Tyson; Claudia Pedroza; Wally A Carlo; David K Stevenson; Ronald Wong; Allison Dempsey; Amir Khan; Rafael Fonseca; Myra Wyckoff; Alvaro Moreira; Robert Lasky
Journal:  JAMA Pediatr       Date:  2020-07-01       Impact factor: 16.193

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.